Medical College of Wisconsin
CTSIResearch InformaticsREDCap

CURRICULUM VITAE

Daniel J. Stein BS, MD
Director, Professor
Department of Medicine
Division of Medicine Gastroenterology and Hepatology

OFFICE ADDRESS:
9200 West Wisconsin Avenue
Milwaukee, WI 53226

EDUCATION:
08/1994 - 05/1998 B.S. - Biology, Marquette University, Milwaukee, WI
08/1999 - 05/2003 M.D., Creighton University School of Medicine, Omaha, NE

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/01/2003 - 06/30/2006 Internal Medicine Internship and Residency, Internal Medicine, University of Arizona, Tucson, AZ
07/01/2007 - 06/30/2010 Gastroenterology and Hepatology Fellowship, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
11/01/2009 - 12/01/2009 Visiting Inflammatory Bowel Disease Fellow, Medicine, Gastroenterology, University of Chicago, Chicago, IL

FACULTY APPOINTMENTS:
07/01/2010 - 06/30/2016 Assistant Professor, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
07/01/2016 - 06/30/2025 Associate Professor, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
07/01/2025 - Present Professor, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
07/01/2006 - 06/30/2007 Chief Resident - Internal Medicine, Internal Medicine, University of Arizona Internal Medicine, Tucson, AZ
08/2013 - 2020 Access Champion for the Division of Gastroenterology and Hepatology, Internal Medicine, Gastroenterology and Hepatology, Froedtert and the Medical College of Wisconsin, Milwaukee, WI
06/01/2015 - 06/30/2026 Medical Director of the Inflammatory Bowel Disease Program at Froedtert and the Medical College of Wisconsin, Internal Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
04/2023 - Present Department of Medicine Vice Chair for Education, Internal Medicine, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
2014 - 2024 Director/Co-Director, M2 GI and Nutrition Subunit, Discovery Curriculum, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
07/01/2016 - 06/30/2025 Fellowship Program Director, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
01/2022 - Present Block Director, Inflammatory Bowel Disease Integrated Science Selective Block. Phase 3 MCWFusion Curriculum, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
07/01/2022 - 12/31/2025 Co-Director Gastroenterology and Nutrition Block. Phase 1. MCWFusion Curriculum, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
07/01/2025 - 06/30/2026 Associate Program Director, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
06/03/2010 - Present Children's Hospital of WI, Milwaukee, WI
07/01/2010 - Present Froedtert Hospital, Milwaukee, WI
09/07/2010 - Present Froedtert Surgery Center, Milwaukee, WI
07/01/2011 - Present Zablocki VA Medical Center, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Internal Medicine
08/2006
12/2016
Gastroenterology
10/31/2010
None
   
Certificates
Issued By Issue DateExpiration
BLS
American Heart Association
03/2014
03/2023
ACLS
American Heart Association
07/2014
09/2023
Business of Medicine for UME-GME Faculty 2026
Alliance for Academic Internal Medicine
05/29/2026
None
    

AWARDS AND HONORS:
1998 Phi Beta Kappa , Marquette University
1998 Magna Cum Laude, Marquette University
05/2000 - 08/2000 Crohn’s and Colitis Foundation of America: 2000 Solvay Pharmaceuticals Student Research Fellowship “Selective Leukocyte Binding by Microvascular Endothelial Cells in Crohn’s Disease”, Medical College of Wisconsin
2005 - 2007 Associate Representative, American College of Physicians
2005 Selected Attendee to 3rd Annual Choosing a Career in Academic Gastroenterology Conference, Medical College of Wisconsin – Division of Gastroenterology and Hepatology
2008 Attendee, IBD Mentoring Program for GI Fellows
2010 Fellowship2Leadership, Salix Fellows Program, DDW
2013 MCW Outstanding Medical Student Teacher Pin, Medical College of Wisconsin
2014 MCW Outstanding Medical Student Teacher Pin, Medical College of Wisconsin
2018 MCW Outstanding Medical Student Teacher Pin, Medical College of Wisconsin
11/06/2020 Catalyst for Mission Advancement Award, Crohn's & Colitis Foundation
01/15/2021 High-Performing Reviewer for Inflammatory Bowel Diseases, Inflammatory Bowel Diseases Journal
2023 2023 Department of Medicine James M. Cerletty Award for Excellence, Medical College of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
07/01/2007 - Present American College of Gastroenterology (Member)
07/01/2007 - Present Crohn's and Colitis Foundation of America (Professional Member)
07/01/2007 - 07/01/2012 American Society for Gastrointestinal Endoscopy (Member)
07/01/2007 - Present American Gastroenterological Association (Member)
08/01/2011 - Present Milwaukee GI Society (Member)
2016 - Present Alliance for Academic Internal Medicine (Member)
2025 - Present Society of Teaching Scholars Medical College of Wisconsin (Inductee)
02/24/2026 - Present Association of Professors of Medicine - Alliance for Academic Internal Medicine (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
2015 - Present Inflammatory Bowel Disease
2017 Gastroenterology and Hepatology Review
2018 Clinical Gastroenterology and Hepatology
2022 Digestive Disease Sciences (DDS)
2022 BMJ Open
2024 - Present Crohn's and Colitis 360

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2010 - 2020 Board Member, Crohn's and Colitis Medical Advisory Board Milwaukee, Crohn's and Colitis Foundation - Wisconsin Chapter
2012 - 2022 Director, Annual Inflammatory Bowel Disease Update, Medical College of Wisconsin Inflammatory Bowel Disease Annual Update
2015 - Present Board Member, Wisconsin Chapter Board, Crohn's and Colitis Foundation
2016 - 2018 Secretary, Milwaukee Gastroenterological Society
2019 - 2021 President, Milwaukee Gastroenterological Society
2022 - Present Chair, Healthcare Professionals Education Committee, Crohn's and Colitis Foundation - Wisconsin Chapter

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2018 - Present Member, Marquette Mentors Leadership Council, Marquette University Alumni Association
2022 - 2024 Member, Advocacy Council, American Gastroenterological Association
2024 - 2027 Member, Professional Education Workgroup, Crohn's & Colitis Foundation's National Scientific Advisory Committee (NSAC)
2024 - 2027 Member, Advanced IBD Fellows workgroup, Crohn's & Colitis Foundation's National Scientific Advisory Committee (NSAC)

INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
03/15/2023 - Present Member, Education Committee - GI Fellowship Program, University of Rwanda

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
The Prevention of Recurrence of Clostridium Difficile Colitis with Ursodeoxycholic Acid Supplementation
Source:
Barbour Fund for GI Fellowship Research
Role & Effort:
Sub-Principal Investigator
PI:
Paraj Patel MD
Dates:
01/08/2025 - Present
  
Non-Peer Review
Title:
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
Source:
Crohn’s and Colitis Foundation
Role & Effort:
Sub-Investigator
Dates:
2017 - Present
  
Title:
A Phase 2b Randomized, Double-blind, Active- and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn's Disease.
Source:
Janssen
Role & Effort:
Principal Investigator
Dates:
2022 - Present
  
Title:
A Phase 2b Randomized, Double-blind, Active- and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colitis.
Source:
Janssen
Role & Effort:
Principal Investigator
Dates:
2022 - Present
  
Title:
AGA FMT National Registry
Source:
American Gastroenterological Association
Role & Effort:
Principal Investigator
Dates:
2023 - Present
  
Title:
PIANO Registry. Pregnancy in Inflammatory bowel disease And Neonatal Outcomes registry: long-term outcomes of in-utero biologic and thiopurine exposure
Source:
Crohn’s and Colitis Foundation Clinical Research Alliance
Role & Effort:
Sub-Investigator
PI:
Poonam Beniwal-Patel MD
Dates:
2023 - Present
  
Title:
A multicenter, multinational, randomized, double-blind, placebo-controlled Phase 3, maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease
Source:
Sanofi
Role & Effort:
Principal Investigator
Dates:
2026 - Present
  
Title:
A multicenter, multinational, randomized, double-blind, placebo-controlled Phase 3, induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s Disease
Source:
Sanofi
Role & Effort:
Principal Investigator
Dates:
2026 - Present
  
Title:
SPECIMEN COLLECTION FROM PARTICIPANTS DUE FOR COLORECTAL CANCER SCREENING, SURVEILLANCE, OR TREATMENT: “IMPACT”
Source:
Exact Sciences
Role & Effort:
Principal Investigator
Dates:
2026 - Present
  
Title:
A multicenter, multinational, randomized, double-blind, placebo-controlled Phase 3, induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis
Source:
Sanofi
Role & Effort:
Principal Investigator
Dates:
2026 - Present
  
Title:
A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants with Moderately to Severely Active Ulcerative Colitis
Source:
Sanofi
Role & Effort:
Principal Investigator
Dates:
2026 - Present
  
Title:
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Source:
Johnson & Johnson
Role & Effort:
Principal Investigator
Dates:
2026 - Present
  
Prior
Non-Peer Review
Title:
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects with Moderately to Severely Active Crohn's Disease (CD)-P06-134
Source:
AbbVie (prior sponsor, Abbott)
Role & Effort:
Principal Investigator
Dates:
2007 - 2026
  
Title:
A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab (MLN0002) in Patients with Ulcerative Colitis and Crohn’s Disease
Source:
Millennium
Role & Effort:
Principal Investigator
Dates:
2009 - 2018
  
Title:
A Non-Interventional Long-term Post Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia®) for Crohn's Disease-SECURE
Source:
UCB Pharma
Role & Effort:
Principal Investigator
Dates:
2010 - 2021
  
Title:
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)
Source:
Legacy (AbbVie)
Role & Effort:
Principal Investigator
Dates:
2013 - 2026
  
Title:
A Phase III Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease-RHB-104-01
Source:
RedHill Biopharma Limited
Role & Effort:
Principal Investigator
Dates:
2014 - 2016
  
Title:
PHASE III, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ETROLIZUMAB DURING INDUCTION AND MAINTENANCE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE REFRACTORY TO OR INTOLERANT OF TNF INHIBITORS-GA28950
Source:
Genentech Inc. (Hoffman-LaRoche)
Role & Effort:
Principal Investigator
Dates:
2014 - 2016
  
Title:
A Multicenter, Open-Label Study to Evaluate the Long Term Effacacy, Safety, and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn's Disease-M14-347
Source:
AbbVie
Role & Effort:
Principal Investigator
Dates:
2014 - 2016
  
Title:
A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis-M14-033
Source:
AbbVie
Role & Effort:
Principal Investigator
Dates:
2014 - 2017
  
Title:
An Open-Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase III Studies-GA28951
Source:
Genentech, Inc.(Hoffmann-La Roche)
Role & Effort:
Principal Investigator
Dates:
2014 - 2016
  
Title:
Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naive to TNF Inhibitors-GA29102
Source:
Genentech, Inc.(Hoffmann-La Roche)
Role & Effort:
Principal Investigator
Dates:
2015 - 2016
  
Title:
A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration-M14-115
Source:
AbbVie
Role & Effort:
Principal Investigator
Dates:
2015 - 2017
  
Title:
Study of FS-0809, Oral FMT Capsules, for Yreatment of Recruitment Closttridium difficle infection-PR#032016-1
Source:
FloraSeq
Role & Effort:
Principle Investigator
Dates:
2016 - 2018
  
Title:
The Association Between Body Composition and Response to Therapy in Inflammatory Bowel Disease Patients.
Source:
Medical College of Wisconsin, Digestive Disease Center
Role & Effort:
Sub-Investigator
PI:
Andres Yarur
Dates:
2016 - 2023
  
Title:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis-M14-234
Source:
AbbVie
Role & Effort:
Principal Investigator
Dates:
2017 - 2020
  
Title:
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Source:
AbbVie
Role & Effort:
Principal Investigator
Dates:
2018 - 2020
  
Title:
A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis-M14-533
Source:
AbbVie
Role & Effort:
Principal Investigator
Dates:
2018 - 2020
  
Title:
Correlation Between Vedolizumab Serum Levels, Anti-Vedolizumab Antibodies, and Disease Activity in Subjects with IBD.
Source:
Prometheus Labs
Role & Effort:
Sub-Investigator
PI:
Andres Yarur
Dates:
2018 - 2020
  
Title:
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Phase 1b Study to Evaluate the Safety, Efficacy and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment
Source:
Assembly Biosciences
Role & Effort:
Sub-Investigator
Dates:
2019 - 2021
  
Title:
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease (APD334-202)
Source:
Arena Pharmaceuticals
Role & Effort:
Sub-Investigator
Dates:
2019 - 2022
  
Title:
The PROP-RD Study: A Prospective Registry for the Study of Outcomes and Predictors in Pouchitis and Pouch-Related Disorders (PROP-RD)
Source:
University of North Carolina Chapel Hill
Role & Effort:
Sub-Investigator
PI:
Poonam Beniwal-Patel, MD
Dates:
2019 - 2022
  
Title:
A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem cells (eASC), for the treatment of complex perianal fistula(s) in patients with Crohn’s disease over a period of 24 weeks and a follow-up period up to 52 weeks-ADMIRE-CD II
Source:
Takeda (TIGENIX, S.A.U)
Role & Effort:
Sub-Investigator
PI:
Poonam Beniwal-Patel, MD
Dates:
2019 - 2023
  
Title:
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis. (APD334-301)
Source:
Arena
Role & Effort:
Sub-Investigator
Dates:
2019 - 2022
  
Title:
A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (TA799-007)
Source:
Takeda
Role & Effort:
Sub-Investigator
PI:
Amir Patel, MD
Dates:
2020 - 2023
  
Title:
Presence of SARS-CoV-2 in stool samples of COVID-19 cases: Potential for Transmission Via Stool Shedding.
Source:
Advancing a Healthier Wisconsin Endowment
Role & Effort:
Sub-Investigator
PI:
Andres Yarur MD
Dates:
2020 - 2022
  
Title:
Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: The OPTIMIZE Trial
Source:
Beth Israel Deaconess Medical Center/Helmsley Charitable Trust
Role & Effort:
Sub-Investigator
Dates:
2021 - 2022
  
Title:
Study to Asses the Genotype of Subjects with Diagnosis of Ulcerative Colitis or Crohns Disease (The PRELUDE Study)
Source:
Prometheus Biosciences
Role & Effort:
Sub-Investigator
Dates:
2022 - 2026
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Daniel Stein, MD, Inflammatory Bowel Disease and Complications, Rwanda GI Resident/Fellowship Program Collaboration Visit, King Faisal Hospital, Kigali, Rwanda, 03/14/2023
Daniel Stein, MD, C. Difficile infection / Enteric Infection, Rwanda GI Resident/Fellowship Program Collaboration Visit, King Faisal Hospital, Kigali, Rwanda, 03/15/2023
Daniel Stein, MD, Celiac Disease, Rwanda GI Resident/Fellowship Program Collaboration Visit, King Faisal Hospital, Kigali, Rwanda, 03/15/2023
 
National
Gluten Sensitivity Disorders, 50th Annual Medical College of Wisconsin Clinical Conference, Clearwater Beach, FL, 02/29/2016 - 03/04/2016
Inflammatory Bowel Disease for the Non-GI Provider, 50th Annual Medical College of Wisconsin Clinical Conference, Clearwater Beach, FL, 02/29/2016 - 03/04/2016
Technological Advances in Inflammatory Bowel Disease, American Gastroenterological Association (AGA) Institute Council, San Diego, CA, 05/21/2021 - 05/24/2021
New Agents for IBD: Biosimilars for all?, Digestive Disease Week (DDW), Clinical Symposium, Virtual, 05/23/2021
Beyond Small Molecules for IBD, IN/WI Patient Education program, Chicago, IL, 12/05/2021
 
Regional
Optimizing Therapy in Crohn's Disease, Medical College of Wisconsin Inflammatory Bowel Disease Update, Medical College of Wisconsin, 03/31/2012
Optimizing Therapy for Inflammatory Bowel Disease, Grand Rounds St. Agnes Hospital, Fond Du Lac, Wisconsin, 05/31/2012
Celiac Disease and Gluten Sensitivity, Medical College of Wisconsin Internal Medicine Grand Rounds, Milwaukee, WI, 04/05/2013
Therapeutic Drug Monitoring In Inflammatory Bowel Disease Patients, Medical College of Wisconsin IBD Update, Milwaukee WI, 04/13/2013
Disease and Drug Monitoring in Inflammatory Bowel Disease, MCW IBD Annual Update, Crowne Plaza Hotel - Wauwatosa, WI, 03/15/2014
Approach to Chronic Diarrhea, State of the Gut, Brookfield, WI, 09/19/2014
Modern Approach to Managing Inflammatory Bowel Disease, WSGNA 2014 Fall Conference, Brookfield, WI, 11/07/2014
Update on Crohn’s Disease Therapy, MCW IBD Annual Update, Milwaukee, WI, 03/14/2015
Modern Disease Management In Inflammatory Bowel Disease, CCFA Wisconsin Patient Education Program, Milwaukee, WI, 04/27/2015
Approach to Patient Care and Research at the Inflammatory Bowel Disease Program at the Medical College of Wisconsin, Digestive Disease Committee Pro-Am Golf Tournament Fundraiser, Milwaukee, WI, 08/24/2015
Digestive Disease Week Review - Inflammatory Bowel Disease, Digestive Disease Week Review, Milwaukee, WI, 09/17/2015
Clostridium Difficile Update, "State of the Gut" An Update on Gastrointestinal Disorders, Brookfield, WI, 09/18/2015
Inflammatory Bowel Disease Patient Question and Answers, Crohn's and Colitis Foundation of America Wisconsin Chapter Meeting, Milwaukee, WI, 10/03/2015
Inflammatory Bowel Disease: Taking Control of Your Disease, Froedtert Community Health Education Series, Milwaukee, WI, 11/03/2015
Non-Celiac Gluten Intolerance, 46th Annual Winter Refresher Course for Family Medicine, Pewaukee, WI, 02/04/2016
Inflammatory Bowel Disease: Taking Control of Your Disease., Froedtert Community Health Education Series, Milwaukee, WI, 02/11/2016
Stopping and De-escalating therapy in IBD, 2016 MCW IBD Update, Milwaukee WI, 03/12/2016
Complementary and Alternative Therapies, MCW Patient and Family Crohn's and Colitis Program, Milwaukee WI, 03/12/2016
Crohn's and Colitis: Taking Control of Your Disease, Carroll College and CCFA Patient Education Program, Waukesha, WI, 03/22/2016
Clostridium difficile update: what's new for an old problem?, CME Committee for the Medical Staff of St. Agnes Hospital, St Agnes Hospital/Fond du Lac Regional Clinic, 04/07/2016
Crohn’s and Colitis, Fall Community Education Class, Community Conference Center - Milwaukee, WI, 09/15/2016
Gluten Sensitivity Disorders, Wisconsin Academy of Physician Assistant (WAPA) 2016 Fall Conference, Osthoff Resort in Elkhart Lake, WI, 10/13/2016
IBD Management Update, Wisconsin Patient Education Program, Zoofari Conference Center - Milwaukee, WI, 12/03/2016
Modern approach to treating inflammatory bowel disease, MCW Department of Dermatology Academic Half Day Conference, Froedtert Specialty Clinics Building, 01/25/2017
Alternatives to colonoscopy, Winter Refresher Course, Milwaukee Marriott West - Waukesha, WI, 02/03/2017
UGI bleeding, Pulmonary and Critical Care Grand Rounds, Froedtert Hospital - Milwaukee, WI, 03/03/2017
IBD IMITATORS, 2017 MCW IBD Update, Embassy Suites - Brookfield, WI, 03/11/2017
Complementary & Alternative Medicine in Inflammatory Bowel Disease, Crohn's and Colitis Patient and Family Education Program, Brookfield, WI, 03/11/2017
Inflammatory Bowel Disease, Wisconsin Academy of Physician Assistants (WAPA) Spring Conference, Osthoff Resort in Elkhart Lake, 10/12/2017
Judge for posters, Department of Medicine 4th Annual Research Retreat, Harley-Davidson Museum - Milwaukee, WI, 03/09/2018
Stopping Meds in IBD, Crohn’s and Colitis Foundation Conference: A Patient and Provider Point of Care Conference, Brookfield, WI, 05/12/2018
Celiac Disease, "State of the Gut” 2018, Brookfield, WI, 09/28/2018
What Is The Best Way To Deal With Anxiety and Depression in IBD Patients?, Crohn’s and Colitis Foundation Conference, Milwaukee, WI, 05/12/2019
Update on IBD, IN/WI Patient Education program, Virtual, 12/05/2020
Celiac Disease and Gluten Sensitivity Disorders, Medicine Grand Rounds, Zablocki Veterans Affairs Medical Center, 08/27/2021
 
Local
Probiotics and Inflammatory Bowel Disease, Crohn’s and Colitis Foundation of America – Milwaukee Chapter Monthly Meeting, Milwaukee, WI, 05/10/2010
New Therapies in IBD, Crohn’s and Colitis Foundation of America – Milwaukee Chapter Monthly Meeting, Milwaukee, WI, 06/07/2010
Inflammatory Bowel Disease and The Endoscopy Lab, Froedtert Lutheran Memorial Hospital Gastroenterology Nursing Education Program, Milwaukee, WI, 08/03/2010
Update on the IBD Center, Digestive Disease Center Board Meeting, Milwaukee, WI, 10/2010
Lunch and Learn “The Celiac Iceberg”, Plank Road Clinic, Milwaukee, WI, 03/03/2011
Lunch and Learn “The Celiac Iceberg”, Sunnyslope Clinic, Milwaukee, WI, 03/16/2011
Lunch and Learn “The Celiac Iceberg”, Lincoln Avenue Clinic, Milwaukee, WI, 04/13/2011
Autonomic Dysfunction and the Gut, Milwaukee Autonomic Support Group, Milwaukee, WI, 02/2013 - Present
Optimizing Therapy for Crohn's Disease, Pharmacy Department Meeting, Milwaukee, WI, 02/10/2014
IBD and the Endoscopy Lab, Building a Better Team - Share Your Knowledge, Milwaukee, WI, 02/12/2014
Modern Disease Management in IBD, Allergy and Immunology Grand Rounds, Children's Hospital of Wisconsin, 03/07/2014
Update on the Inflammatory Bowel Disease Program, Digestive Disease Board Meeting 6/1/2015, Milwaukee, WI, 06/01/2015
Approach to Upper GI Bleeding in the CVICU, CVICU Lecture Series, Milwaukee, WI, 06/09/2015
Integrating Clinical and Basic Sciences Into a Single Educational Experience, MCW Innovations in Medical Education Conference, Milwaukee, WI, 04/28/2016
GI Bleeds in the CVICU Population: Prevention and Treatment, CVICU Lecture series, Milwaukee, WI, 06/21/2016
IBD, 2016 Digestive Disease Week Meeting Review, Milwaukee, WI, 10/01/2016
The Gut Microbiome and You, AHW Endowment’s Conversations with Scientists Fall series, Milwaukee, WI, 10/26/2016
Diarrhea, 2017 Symptoms Unit of the M-2 Discovery Curriculum, Milwaukee, WI, 04/11/2017
Crohn's and Colitis: Looking Like Crap from the Inside Out, Milwaukee IBD Education Conference (Crohn's & Colitis Foundation), Zootopia Conference Center - Milwaukee, WI, 12/02/2017
Introduction to Crohn’s Disease and Ulcerative Colitis, Spring Community Education Class, Community Conference Center, 03/06/2018
Inflammatory Bowel Disease, DDW Review, Brookfield, WI, 09/14/2019
Gluten Sensitivity Spectrum, GIM Noon Conference, Zablocki VA - Milwaukee, WI, 10/30/2019
Celiac Disease and Gluten Sensitivity Disorders: Is Gluten Really Evil?, Gastroenterology Grand Rounds, Froedtert Hospital, Milwaukee, WI, 11/15/2019
Navigating Healthcare in a New World, Lunch and Learn Webinar for the Crohn's and Colitis Foundation - WI Chapter, Milwaukee, WI, 06/01/2020
Celiac Disease and Gluten Sensitivity Disorders: Is Gluten Really Evil?, GIM Seminar Series, Medical College of Wisconsin, 05/21/2021
MyIBD Learning Live and Ondemand, MyIBD Learning, Virtual, 10/02/2021
Difficult Cases, stopping medications, combo therapy, and other situations. IBD Panel Discussion, Crohn’s and Colitis Foundation Conference: A Patient and Provider Point of Care Conference, Wauwatosa, WI, 05/07/2022
Daniel Stein, MD, Celiac Disease, The Department of Medicine Grand Rounds, Medical College of Wisconsin, Milwaukee, WI, 01/19/2024
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Stein,D et. al., Inflammatory Bowel Disease Patients on Immunosuppressive Therapy in Endoscopic Remission Have a High Rate of Post Inflammatory Bowel Disease-Irritable Bowel Syndrome which is Associated with a Diminished Quality of Life., Digestive Disease Week 2012, San Diego, CA, 05/19/2012 - 05/22/2012
Modiri, A, Stein, D, et al, Inflammatory Bowel Disease Patients With Solid Organ Transplants Who Require Anti-TNF Therapy Are Not at Increased Risk of Serious Infections., Digestive Disease Week 2015, Washington D.C., 05/16/2015 - 05/19/2015
 

COMMITTEE SERVICE:
Medical College of Wisconsin
2011 - Present Interviewer, Internal Medicine Residency Program Applicants, Medicine, Medical College of Wisconsin
2011 - Present Interviewer, Gastroenterology Fellowship Program Applicants, Gastroenterology and Hepatology, Medicine, Medical College of Wisconsin
2012 - 2024 Member, M2 Unit Directors Committee, Medicine, Medical College of Wisconsin
2013 - 2020 Member, Department of Medicine Access Champion Committee, Gastroenterology and Hepatology, Medicine, Medical College of Wisconsin
2014 - Present Member, Division of Gastroenterology and Hepatology Faculty Recruitment Committee, Gastroenterology and Hepatology, Medicine, Medical College of Wisconsin
2014 - 2025 Member, Directors of Medical Student Education Committee, Medical College of Wisconsin
2015 Member, Bonus Distribution Guideline Development Task Force, Medicine, Medical College of Wisconsin
2015 - Present IBD Research Committee, Gastroenterology and Hepatology, Medicine, Medical College of Wisconsin
2016 - Present Member, Fellowship Clinical Competency Committee, Gastroenterology and Hepatology, Medicine, Medical College of Wisconsin
2016 - 2024 Moderator, ACP / Student Networking. Aimed at increasing student interest in Internal Medicine and Medicine Sub-Specialties., Medical College of Wisconsin
2016 - 2017 Member, Cardiology Chief Search Committee, Cardiovascular Medicine, Medicine, Medical College of Wisconsin
2016 - 2017 Chair, Digestive Disease Committee 2017 Grant Review Committee, Gastroenterology and Hepatology, Medicine, Medical College of Wisconsin
2016 - 2019 Member, Associate Vice Chair Ambulatory Operations Committee, Medicine, Medical College of Wisconsin
2017 - 2025 Member, MCWAH Graduate Medical Education Committee (GMEC), MCWAH
2017 - Present Member, Medical College of Wisconsin Affiliated Hospital’s (MCWAH) Program Review Subcommittee, MCWAH
2018 - 2023 Member, DOM Research Retreat Committee, Medicine, Medical College of Wisconsin
2018 Team Lead, MCWAH Special Full Review - Allergy and Immunology Fellowship Program, MCWAH
2019 - 2021 Member, Faculty Council, Medicine, Medical College of Wisconsin
2020 - Present Member, MCWAH Research and Quality Award Committee, MCWAH
2020 - 2022 Member, Curriculum Exploration Steering committee, Medical College of Wisconsin
2021 Member, CEC ad hoc Inter-campus Comparability Committee, Medical College of Wisconsin
2023 - 2024 Member, Designated Institutional Official (DIO) Search Committee, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin
2023 - Present Member, Chair's Cabinet, Medicine, Medical College of Wisconsin
2023 - Present Member, Vice-Chair Committee, Medicine, Medical College of Wisconsin
09/2024 - Present Sponsor, Team Based Care Capstone Project - Leadership Academy, Medical College of Wisconsin
2024 Member, Colorectal Surgeon Search Committee, Surgery, Medical College of Wisconsin
2024 - Present Chair, Inflammatory Bowel Disease Recruitment Committee, Gastroenterology and Hepatology, Medicine, Medical College of Wisconsin
2025 - 2026 Member, LCME Self Study Task Force Standard 11, Medicine, Medical College of Wisconsin
2025 - 2026 Member, LCME Self Study Task Force - Standard 9, Medicine, Medical College of Wisconsin
2026 - Present Member, Colorectal Surgeon Search Committee, Surgery, Medical College of Wisconsin
 
Hospital
2014 - 03/2017 Member, Ambulatory Care Pharmacy and Therapeutics Committee, Froedtert and Medical College of Wisconsin
2015 - 2018 Member, Specialty Pharmacy/340B Advisory Group, GI, Pharmacy, Froedtert Hospital and Medical College of Wisconsin
01/2016 - 07/2019 Committee Member, MCP Patient Services and Operations Committee, Medical College Physicians
2016 - 2017 Member, Combined Ambulatory PNT & Therapeutics Committee, Gastroenterology and Hepatology, Medicine, Froedtert and MCW
08/2017 - 2019 Member, GI Optimization Meeting, Gastroenterology and Hepatology, Department of Medicine, Froedtert and Medical College of Wisconsin
2017 - 2020 Member, Nutrition Committee, Medicine, Gastroenterology and Hepatology, Froedtert and Medical College of Wisconsin
2018 - 2020 Member, Social Dyad, Gastroenterology and Hepatology, Medicine, Froedtert and Medical College of Wisconsin
2018 - 2020 Member, No-Show/Same Day Cancellations Workgroup, Froedtert and Medical College of Wisconsin
 

MCW TEACHING ACTIVITIES:
Medical Student Education
2010 - Present M4 Inflammatory Bowel Disease Rotation Attending
2010 - Present GI Consult Rotation: Outpatient Clinic Attending
2011 - 2026 Ambulatory Clinics Rotation Attending
2013 - Present M1 Clinical Apprenticeship/Early Clinical Learning (Climb) Preceptor
01/2014 - 01/2024 M2 GI&N Subunit Lecture Miscellaneous Disorders of the GI Tract
01/2014 - 01/2024 M2 GI&N Subunit Lecture Approach to Diarrhea
01/2014 - 01/2024 M2 GI&N Subunit Lecture: Celiac Disease
01/2014 - 01/2024 M2 GI&N Subunit Lecture C. Difficle Colitis
01/2014 - 01/2024 M2 GI&N Subunit Lecture: Case of Weight Loss and Diarrhea
01/2014 - 01/2024 M2 GI&N Subunit Lecture: Introduction to Inflammatory Bowel Disease
01/2014 - 01/2024 M2 GI&N Subunit Lecture: Pathology of the Esophagus and Stomach - Case Presentation
08/31/2016 Bench to Bedside - Preceptor Session - Clinical Reasoning Exercise
08/28/2019 M2 Bench to Bedside course
11/2023 - 11/2025 MCWFusion GI&N Subunit Lecture Approach to Diarrhea
11/2023 - 11/2025 MCWFusion GI&N Subunit Lecture: Introduction to Inflammatory Bowel Disease
11/2023 - 11/2025 MCWFusion GI&N Subunit Lecture: Celiac Disease
11/2023 - 11/2025 MCWFusion GI&N Subunit Lecture Miscellaneous Disorders of the GI Tract
 
Resident and Fellow Education
06/01/2010 - Present GI Fellow Board Review: IBD and Infections of the GI Tract
07/01/2010 - Present Quality Assurance Meeting: GI Division Recurring Meeting
07/01/2010 - Present Journal Club: GI Fellows (Recurring Meeting)
07/01/2012 - Present Attending: GI Fellow Continuity Clinic
07/01/2012 - Present Internal Medicine Noon Report Faculty
12/2012 - Present Lecture: Management of Inflammatory Bowel Disease for the Internist
04/2013 - Present Introduction to Endoscopy for First Year Surgical Resident
12/16/2013 Lecture: Introduction to Inflammatory Bowel Disease
12/10/2015 Resident Academic Halfday lecture: Advanced IBD
12/07/2016 Academic Half Day Lecture: IBD
03/06/2017 PGY 2 Lecture: Medical Mgmt of IBD
11/29/2017 Academic Half Day Lecture, Residents: C diff & Enteric Infections
09/03/2019 GI Clinical Pathology Conference (VA Zablocki)
12/04/2019 Academic Half Day Lecture-Residents (Celiac Sprue)
12/09/2020 Academic Half Day Lecture (Residents) C-Diff
05/26/2021 Academic Half Day Lecture (Interns)-Diarrhea/Constipation
11/10/2021 Academic Half Day Lecture-Residents: Small/Large Bowel Disease
11/09/2022 Academic Half Day Lecture-Residents: Small/Large Bowel Disease
10/18/2023 Academic Half Day Lecture-Residents: Ulcerative Colitis/Crohn’s-Inpatient and Outpatient Management
10/25/2023 Academic Half Day Lecture-Interns: Diarrhea-Osmotic, Post-Surgical, Bile Salt-Induced, Nocturnal, Gastric Bypass Complications, Antibiotic-Induced
01/2024 Academic Half Day Lecture-Residents: Ulcerative Colitis/Crohn’s-Inpatient and Outpatient Management
 
Continuing Medical Education
09/05/2019 GI Clinical Pathology Conference (Froedtert Hospital)
11/15/2019 DOM Grand Rounds - Topic: “Celiac Disease and Gluten Sensitivity Disorders: Is Gluten Really Evil?"
01/19/2024 DOM Gastroenterology Grand Rounds:"Celiac Sprue"
 
Community/Lay Public
10/26/2016 Conversations with Scientists: It’s Contagious - The World of Infectious Disease evening program
 

EXTRAMURAL TEACHING:
Resident and Fellow Education
03/14/2023 University of Rwanda, University Teaching Hospital of Kigali
 
Continuing Medical Education
05/04/2017 Watertown Memorial Hospital, Celiac Syndrome: The truth and facts of celiac disease
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
2013 - 2014 Imaan Ansari, Research Mentor, Medical College of Wisconsin, Accepted to Residency
2014 - 2017 David Ingram, Quips Advisor/Scholarly Pathway, Medical College of Wisconsin, Accepted to Residency
2018 - 2020 Alexander Chartier, Academic Advisior, Medical College of Wisconsin, Accepted to Residency
2019 - 2022 Mir Zulqarnain, Academic Advisor, Medical College of Wisconsin, Matched into Fellowship
2020 - 2022 Clara Bosco, Academic Advisor, Medical College of Wisconsin, Matched into Surgery Residency
01/03/2022 - Present Sparsh Jain, Pathways Advisor/Project Mentor, Medical College of Wisconsin, Match ENT residency
01/13/2022 - 2024 Adam Kelly, 4th Year advisor, Medical College of Wisconsin, Match into Internal Medicine
2022 - 2024 Brittany Doll, Academic Advisor, Medical College of Wisconsin, Matched into Medicine Residency
2022 - 2024 Amber Bo, Academic Advisor, Medical College of Wisconsin, Matched into Anesthesia Residency
2022 - 2024 Julia Bosco, Academic Advisor, Medical College of Wisconsin, Matched into Surgery Residency
2024 - Present Annie Kleynerman, Residency Advisor, Medical College of Wisconsin, Pending Graduation
 
Clinical/Research Fellows
07/01/2009 - 06/30/2011 James Kwiatt, Research Mentor, Medical College of Wisconsin, Published Abstract
06/01/2012 - 06/01/2014 Syed Rizvi, Research Mentor, Medical College of Wisconsin, Published Abstract and Paper
07/01/2012 - 06/30/2013 Mukund Venu, Research Mentor, Medical College of Wisconsin, Published Abstract and Paper
07/01/2012 - 12/30/2014 Amar Naik, Research Mentor, Medical College of Wisconsin, Published Abstract
06/01/2014 - 07/01/2017 Alexandra Modiri, Research Mentor, Medical College of Wisconsin, Oral Presentation
06/23/2014 - Present Dilpesh Agrawal, MD, Career Advancement, Medical College of Wisconsin, Promotion Process
2016 - 2018 Atena Lodhi, Research Mentor, Medical College of Wisconsin, Matched into GI Fellowship
 
Residents
06/01/2011 - 07/30/2012 Parin N. Desai, Research Mentor, Medical College of Wisconsin, Published Abstract
07/01/2012 - 06/30/2014 Adeeti Chiplunker, Research Mentor and Academic Advisor, Medical College of Wisconsin, Published Abstract and Matched into GI fellowship
09/01/2014 - 07/01/2017 Jennifer Cahill, Research Mentor and Academic Advisor, Medical College of Wisconsin, Published Abstract
09/12/2016 - 2020 Hasan Bader, Academic mentorship, Medical College of Wisconsin, Accepted To GI fellowship
09/01/2018 - Present Marium Khan, Research and Academic Advisor, Medical College of Wisconsin, Published Book Chapter and Matched into Pulmonary Critical Care Fellowship
2019 - 2023 Haley Mertens, MD., Academic Advisor, Medical College of Wisconsin, Acceptance to GI fellowship
02/2020 - 2023 Shaina Sekhri, MD, Career advancement, Medical College of Wisconsin, Accepted into GI Fellowship at NYU
2020 - 2022 Lauren Johnson MD, Research and Academic Advisor, Medical College of Wisconsin, Published Research and Matched into GI fellowship
2020 - Present Sonya Dave, MD, Research and Academic Advisor, Medical College of Wisconsin, Matched into GI fellowship
 
Faculty
07/01/2012 - 06/30/2015 Vikram Kanagala, Research and Academic Advisor, Medical College of Wisconsin, Published Abstract and Matched into GI Fellowship
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Undergraduate Students
2016 - 2017 Connor O'Neill, Academic mentorship, Marquette University, MCW Faculty Member
2017 - 2018 Jacob Anderson, Academic Mentorship, Marquette University, Graduation
2018 - 2019 Manuel Rafael Garcia, Academic Mentorship, Marquette University, Graduation
2019 - 2020 Viviana Bojorquez, Academic Mentorship, Marquette University, Graduation
2020 - 2022 Radhika Dua, Academic Mentorship, Marquette University, Accepted to Medical School
2022 - 2024 Christine Batliner, Academic Mentorship, Marquette University, Graduation, PA School Acceptance
2022 - 2023 Ivan Rojo, Academic Mentorship, Marquette University, Graduation
2023 - 2024 Armando Rivera, Academic Mentorship, Marquette University, Graduation
2024 - 2025 Peyton Toepher, Academic Mentorship, Marquette University
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Fellow
2010 - Present Visiting IBD Fellow Program: Coordinate and educate visiting GI fellows interested in learning more about the management IBD by rotating through our inflammatory bowel disease program.
2010 - Present GI Fellow IBD/Clinics rotation: Instrumental in the design and development of the GI fellows IBD rotation
2014 - 2026 Inflammatory Bowel Disease Working Group: Director of a monthly multidisciplinary meeting focusing on the management of IBD patients
2018 - Present Fellowship Didactic Sessions and Board Review
 
Research Programs
2018 - Present Parenteral Nutrition Management Team
 
Clinical Programs
2012 - Present Fecal Microbiota Transplant Program: Developed and organized the first regulated fecal microbiota transplant program in Southeastern Wisconsin for the treatment of Clostridium difficile infections.
01/2013 - Present Pharmacist Integration with IBD Program: Integrated pharmacist into IBD program helping to monitor and to teach patients about their immunosuppressive medications.
2013 - 2018 IBD New Patient Intake Program: Developed an efficient and organized program aimed at optimizing the new patient experience for the Inflammatory Bowel Disease Program
02/2014 - Present Gastroenterology Nutritionist Program: Coordinated with Froedtert hospital for nutritionist support in the GI clinic to help manage our IBD, Celiac Disease, and Short Bowel Patients.
2014 - 2019 Inflammatory Bowel Disease Transition Clinic adolescent patients transitioning from the pediatric to adult clinics.
2015 - 2018 Development of IBD Program ADIET Program: Comprehensive program aimed at improving patient satisfaction of all patients in the Inflammatory Bowel Disease Program
2015 - 2026 IBD Program Promotional Development: Work with Medical College Physicians, Froedtert Hospital and the Medical College of Wisconsin to promote the Inflammatory Bowel Disease Program
2017 - Present Gastroenterology Fellowship Continuity Clinic at Froedtert Hospital. Developed and staffed a continuity clinic for GI Fellows at Froedtert Hospital.
 
 

COMMUNITY SERVICE ACTIVITIES:
06/2009 - Present Crohn's and Colitis "Take Steps" Walk to raise money for IBD research. Once yearly fundraising walk - participant and fundraiser.
06/01/2011 - 07/30/2012 Mentor Community Nurse Practitioner Anne Nohl in volunteer Research project. "Autonomic Dysfunction and Inflammatory Bowel Disease"
2011 - 2015 St. Jude's the Apostle Winterfest, yearly, Church festival volunteer.
2015 - 2017 "Pie a GI" at the annual Crohn's and Colitis "Take Steps" Walk to raise money for IBD research. Volunteered to take cream pies in the face for patients who were high fundraisers.
08/01/2016 - Present Marquette University Alumni Association Mentorship Program - Mentor undergraduate student pursuing a career in the health sciences.
12/01/2016 - 03/03/2018 Wauwatosa Recreation Department basketball coach
2016 - 2018 Men of St. Jude's. Group focused on raising funds to benefit the students and community around St. Jude's the Apostle Church
2017 - 2018 20-YEAR Marquette University Reunion + Homecoming 2018 Planning Committee
09/2018 The Word on Medicine Radio Program highlights innovation and discovery at the Medical College of Wisconsin, featuring topic, on Inflammatory Bowel Disease.
2019 - Present Crohn's & Colitis Foundation Autumn Affair Planning Committee and Attendee - Annual Event
06/08/2020 Webinar Recording: Navigating Healthcare in a New World Pt. 1 Drs. Daniel Stein (Froedtert & Medical College of Wisconsin) and Abdul Elkadri (Children's Wisconsin) joined Kelly Fitzgerald, Education Manager, on June 1st to discuss tips for IBD patients to best manage their healthcare as it relates to COVID-19.
06/15/2020 Webinar Recording: Navigating Healthcare Part 2 - discussing tips for IBD patients to best manage their healthcare as it relates to COVID-19.
05/2024 The Word on Medicine Radio Program highlights innovation and discovery at the Medical College of Wisconsin, featuring topic, on Crohn's Disease and IBD.
 

AMERICAN GASTROENTEROLOGICAL ASSOCIATION (AGA) FALL ADVOCACY DAY:
09/23/2021 Participated in AGA Fall Advocacy Day

CAREER DEVELOPMENT ACTIVITIES:
06/08/2015 - 06/10/2015 Workshop developed by the University of Michigan College of Engineering that seeks to deepen the understanding of the Daily Improvement Model that works to improve clinical and administrative efficiency.
2016 - 2026 MCWAH Graduate Medical Education Program Director (PD) Retreat Recurring Meetings
2017 - 2019 2017 and 2018 Training Directors' Workshop
01/23/2018 - 01/24/2018 DYAD Leadership Development Program
02/20/2018 Knowledge Now: Identifying and Maximizing Your Teaching Style
02/22/2018 Kern Institute Grand Rounds: Utilizing Character to Rediscover Joy in the Practice of Medicine
02/03/2020 - Present Wellness 1/2 Day program
03/09/2021 - 03/31/2021 The Clinical & Translational Science Institute of Southeast Wisconsin (CTSI): Multidisciplinary Team Science Workshop Series
03/09/2022 - 03/31/2022 CTSI Multidisciplinary Team Science Workshop Series
08/2023 - 05/2024 Leadership Academy presented by Lubar Executive programs in partnership with Medical College of Wisconsin


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Stein DJ, Ananthakrishnan AN, Issa M, Williams JB, Beaulieu DB, Zadvornova Y, Ward A, Johnson K, Knox JF, Skaros S, Binion DG. Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease. Inflamm Bowel Dis. 2010 Jul;16(7):1173-9.
2. Rafiee P, Stein DJ, Nelson VM, Otterson MF, Shaker R, Binion DG. Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G167-76. PMCID: PMC2822501
3. Nguyen DM, El-Serag HB, Henderson L, Stein DJ, Bhattacharyya A, Sampliner RE. Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2009 Dec;7(12):1299-304.
4. Stein DJ, Hashem B. El-Serag, M.D., M.P.H., John Kuczynski, M.D., Jennifer R. Kramer Ph.D., M.P.H., Richard E. Sampliner, M.D. The Association of Barrett's Esophagus and Body Mass Index. Alimentary Pharmacology & Therapeutics. 2005 Nov 15;22(10):1005-10.
5. Fons ME, Stein DJ, Patel A, Ferrer MS, Ammon H, Mackinnon AC, Komorowski RA, Yan BC. Extracolonic gastrointestinal tract morphologic findings in a case of pseudomembranous collagenous colitis. Ann Diagn Pathol. 2013 Jun;17(3):291-4.
6. Bautista MC, Otterson MF, Zadvornova Y, Naik AS, Stein DJ, Venu N, Perera LP. Surgical outcomes in the elderly with inflammatory bowel disease are similar to those in the younger population. Dig Dis Sci. 2013 Oct;58(10):2955-62.
7. Perera LP, Ananthakrishnan AN, Guilday C, Remshak K, Zadvornova Y, Naik AS, Stein DJ, Massey BT. Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission. Dig Dis Sci. 2013 Dec;58(12):3600-5.
8. Yarur AJ, Kanagala V, Stein DJ, Czul F, Quintero MA, Agrawal D, Patel A, Best K, Fox C, Idstein K, Abreu MT. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Aliment Pharmacol Ther. 2017 Apr;45(7):933-940.
9. Bhandari S, Larson ME, Kumar N, Stein D. Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study. Gut Liver. 2017 Jul 15;11(4):512-519. PMCID: PMC5491086
10. Bhandari S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, Saeian K, Stein D. Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection. Inflamm Bowel Dis. 2017 Oct;23(10):1847-1852.
11. Stein DJ. Massage Acupuncture, Moxibustion, and Other Forms of Complementary and Alternative Medicine in Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2017 Dec;46(4):875-880.
12. Bhandari S, Saeian K, Stein D. Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflamm Bowel Dis. 2018 Feb 15;24(3):661.
13. Beniwal-Patel P, Stein DJ, Munoz-Price LS. The Juncture Between Clostridioides difficile Infection and Inflammatory Bowel Diseases. Clin Infect Dis. 2019 Jul 02;69(2):366-372.
14. Ungaro RC, Yarur A, Jossen J, Phan BL, Chefitz E, Sehgal P, Kamal K, Bruss A, Beniwal-Patel P, Fox C, Patel A, Bahur B, Jain A, Stein D, Naik S, Dubinsky MC. Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease. J Crohns Colitis. 2019 Aug 14;13(8):963-969. PMCID: PMC7185193
15. Mulgund A, Stein D. Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year. Dig Dis Sci. 2020 Dec;65(12):3420-3421.
16. Stein DJ. All Systems Go: Reconsidering Healthcare Costs in Inflammatory Bowel Disease. Dig Dis Sci. 2021 Mar;66(3):660-661. PMCID: PMC7935728
17. Patel P, Iqbal O, Mohananey D, Bajwa S, Khani M, Luo J, Stein DJ, Kochhar GS, Hashash JG, Mansoor E, Cross RK, Sinh P. Safety of biologics and Janus kinase inhibitors in inflammatory bowel disease patients with low cardiovascular risk. Crohns Colitis 360. 2026 Apr;8(2):otag039. PMCID: PMC13189853
18. Sekhri S, Rao B, Mohananey A, Beniwal-Patel P, Bruss A, Stein DJ, Yarur AJ. Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease. BMJ Open Gastroenterol. 2021 Nov;8(1). PMCID: PMC8587383
19. Johnson LK, Munoz-Price S, Patel PB, Patel A, Stein DJ, Yarur AJ. Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for Clostridioides difficile. Ann Gastroenterol. 2022 Mar-Apr;35(2):135-139. doi: 10.20524/aog.2022.0690. Epub 2022 Feb 14. PMID: 35479586; PMCID: PMC8922265.
20. Odufalu FD, Long M, Lin K, Mahadevan U, PIANO Investigators from the Crohn’s and Colitis Foundation (CCF) Clinical Research Alliance recruited patients for their respective centers for participant enrollment. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry. Gut. 2022 Sep;71(9):1766-1772.
21. Zulqarnain M, Jaber F, Jahagirdar V, Alsakarneh S, Gomez J, Stanton A, Patel N, Beniwal-Patel P, Stein D, Otterson M, Yarur AJ. Predictive Factors of Non-Inflammatory Small Bowel Obstruction After Bowel Resection in Crohn's Patients. Gastroenterology Res. 2024 Apr;17(2):64-71. PMCID: PMC11073459
22. Hallcox, T, Stein, D. Esophageal Crohn's Disease Successfully Treated With Risankizumab. ACG Case Rep J. 2026 Feb 27;13(3):e02031. PMCID: PMC12947984
23. Mumm, B, Stein, D. Use of Janus Kinase Inhibitor Upadacitinib in Microscopic Colitis. ACG Case Rep J. 2026 Feb 27;13(3):e02028. PMID: 41767336
 
Books, Chapters, and Reviews
1. Stein DJ, Shaker R. Gastrointestinal Emergencies Third Edition. Complications of Upper Gastrointestinal Endoscopy. Tham T, Collins J, Soetikno R (eds) Wiley Blackwell Publisher. 2013.45-50
2. Stein, DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Can I stop my medications now that I am feeling well? Why maintenance therapy is important at preventing recurrence in Crohn's disease. Stein, DJ (eds) Springer Publishing 2015.91-98
3. Stein DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Was There Something I Did to Get Inflammatory Bowel Disease? Environmental and Dietary Factors That Contribute to IBD. Stein DJ, Kanagala V (eds) Springer Publishing 2015.7-14
4. Stein DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Why Can't I Continue to Take My Narcotics?: The Long Term Negative Effects of Narcotics. Rage A, Stein DJ (eds) Springer Publishing 2015.129-134
5. Stein DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Why Can’t I Just Stay on Prednisone? The Long-Term Adverse Effects of Steroids. Schiro A, Stein DJ (eds) Springer Publishing 2015.119-128
6. Stein DJ. Inflammatory Bowel Disease: A Point of Care Clinical Guide. What Happens If I Do Nothing for My Ulcerative Colitis? The Natural History of Untreated Ulcerative Colitis. Kanagala V, Stein DJ (eds) Springer Publishing 2015.41-51
7. Inflammatory Bowel Disease: A Point of Care Clinical Guide. Stein DJ, Shaker R (eds) Springer Publishing 2015
8. Stein, DJ. Complementary and Alternative Medicine in Inflammatory Bowel Disease. Massage Acupuncture, Moxibustion, and Other Forms of Complementary and Alternative Medicine in Inflammatory Bowel Disease. Keshavarzian Ali, Mutlu Ece A (eds) December 2017.875-880
9. Stein, DJ. Gastrointestinal and Liver Disorders in Women’s Health A Point of Care Clinical Guide Editors. Celiac Disease. Beniwal-Patel P, Shaker R (eds) Springer Publising 2019.177-186
10. Stein, DJ. Managing Complex Cases in Gastroenterology. Ulcerative Colitis Refractory to Mesalamine.Sobin Harley W, Saeian K, Sanvanson P. (eds) Springer Publishing 2024.189-191
11. Stein, DJ. Managing Complex Cases in Gastroenterology. Ulcerative Colitis Refractory to Anti-TNF. Sobin Harley W, Saeian K, Sanvanson P. (eds) Springer Publishing 2024.201-203
12. Stein, DJ. Managing Complex Cases in Gastroenterology. Ustekinumab vs Risankizumab in Crohn's. Sobin Harley W, Saeian K, Sanvanson P. (eds) Springer Publishing 2024.211-213
13. Stein, DJ. Managing Complex Cases in Gastroenterology. Use of Vedolizumab in UC. Sobin Harley W, Saeian K, Sanvanson P. (eds) Springer Publishing 2024.215-217
14. Stein, DJ. Managing Complex Cases in Gastroenterology. Use of Immune Modulators in Patients Being Started on Anti-TNFs. Sobin Harley W, Saeian K, Sanvanson P. (eds) Springer Publishing 2024.225-226
15. Stein, DJ. Managing Complex Cases in Gastroenterology. UC in a Patient Who Failed Mesalamine and Anti-TNF. Sobin Harley W, Saeian K, Sanvanson P. (eds) Springer Publishing 2024.229-230
16. Stein, DJ. Managing Complex Cases in Gastroenterology. Miscellaneous Questions About IBD. Sobin Harley W, Saeian K, Sanvanson P. (eds) Springer Publishing 2024.245-249
 
Abstracts
1. S Kugathasan, Daniel J. Stein, MT Rivera, B Seetharam, DG Binion,: Plasma Transcobalamin II (TC II) is elevated in children with established, but not newly diagnosed Crohn's disease (CD): Acquired alteration in microvascular expression. Gastroenterology, 116: A755, 1999.
2. DG Binion, KS Ramanujam, PJ Fisher, S Fu, MT Rivera, Daniel J. Stein, KT Wilson,: Loss of inducible nitric oxide synthase (iNOS) expression in inflammatory bowel disease (IBD) human intestinal microvascular endothelial cells (HIMEC) underlies leukocyte hyper adhesion.Gastroenterology, 116: A668, 1999.
3. MT Rivera, PJ Fisher, Daniel J. Stein, T Condon, J Tami, WE Shanahan, CF Bennett, DG Binion. Antisense oligonucleotides, but not steroids, inhibit human intestinal microvascular endothelial cell (HIMEC) adhesion molecule expression and leukocyte binding: A novel therapeutic strategy in intestinal inflammation. Gastroenterology, 116: A669, 1999.
4. P Rafiee, PJ Fisher, Daniel J. Stein, CP Johnson, DG Binion,: ICAM-1, but not VCAM-1 expression is blocked with tyrosine phosphorylation inhibitors in activated human intestinal microvascular endothelial cells (HIMEC): Potential role of ERK and p38 MAPK. Gastroenterology, 116: A920, 1999.
5. S Kugathasan, Daniel J. Stein, RL Truitt, DG Binion,: Distinct mucosal T cell phenotypes in early and late pediatric Crohn's disease (CD): Increased naïve T cells are found in late, but not early CD. Gastroenterology, 118: A347, 2000.
6. S Kugathasan, A Taras, Daniel J. Stein, PJ Fisher, TH Lamirand, RL Truitt, DG Binion,: Infliximab binds human monocytes, but not mucosal T cells in vitro: no direct anti-T cell mechanism of action. Gastroenterology, 118: A110, 2000.
7. Daniel J. Stein, P Rafiee, A Taras, TH Lamirand, PJ Fisher, H Ogawa, GL Telford, MF Otterson, CP Johnson, Binion DG,: Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Gastroenterology, 120: A278, 2001.
8. Daniel J. Stein, R Chiou, B Houghton, G Ochuba. "An Unusual Case of Abdominal Pain and Urethritis." 2003 American College of Physicians Annual Session. San Diego, CA. April 3-5.
9. Daniel J. Stein, W Diaz-Calderon, and GL Woods. "Fibrosing Cholestatic Hepatitis: A Rare Complication After Renal Transplant." American College of Physicians - Arizona Chapter Annual Meeting. Tucson, AZ. October 1-2, 2005.
10. Daniel J. Stein, HB El-Serag, J Kuczynski, JR Kramer, and RE Sampliner. "The Association of Barrett's Esophagus and Body Mass Index." American College of Gastroenterology 70th Annual Scientific Meeting. October 30 - November 2, 2005. Honolulu, Hawaii. A587
11. Daniel J. Stein, Mazen Issa, Sue Skaros, Josh F Knox, Kathryn Lemke, Jeanne Emmons, Mary F Otterson, Ashwin N Ananthakrishnan, David G Binion. "History of interrupted infliximab dosing significantly diminishes efficacy during long-term maintenance therapy in Crohn's Disease." Gastroenterology. 134(4), Suppl 1: A-666, 2008.
12. Stein DJ, Ananthakrishnan A, Ulitsky A, Naik AS, Marn C, Sudakoff G, Otterson MF, Perera LP, Binion DG, Issa M. Pre-operative small bowel follow through detects more strictures on a per stricture analysis than CT enterography when compared to intra-operative findings in patients with Crohn's disease. American College of Gastroenterology annual meeting, San Diego, October 2009.
13. Beaulieu DB, Ananthakrishnan AN, Zadvornova Y, Stein DJ, Mepani R, Antonik SJ, Skaros S, Johnson K, Naik AS, Perera LP, Binion DG. Does Duration of Disease Impact Health Related Quality of Life (HRQoL) in Inflammatory Bowel Disease? Digestive Disease Week, Chicago, June 2009
14. Beaulieu DB, Ashwin N Ananthakrishnan, Zadvornova Y, Stein DJ, Mepani R, Antonik SJ, Skaros S, Johnson K, Naik AS, Perera LP, Binion DG. Seasonal variation in HRQoL and disease activity in patients with inflammatory bowel disease: a tertiary care center experience. Gastroenterology 2009;136(Suppl 1): M1158.
15. Daniel J. Stein, Benson T. Massey, Thangam Venkatesan, Richard Komorowski and Walter J. Hogan. Chronic Idiopathic Enterocolitis (CIE): Maintaining a Corticosteroid Free Response with Immunosuppressive Therapy. Digestive Disease Week, New Orleans, May 2010.
16. Zadvornova Y, Ashwin N Ananthakrishnan, Stein DJ, Skaros S, Johnson K, Naik AS, Perera LP, Issa M. Infliximab monotherapy vs. combined infliximab-immunomodulator therapy in ulcerative colitis. Digestive Disease Week, New Orleans, May 2010.
17. Kwiatt, James T., Stein, Daniel J., Naik, Amar S., Ananthakrishnan, Ashwin N., Perera, Lilani P. The 2009 Influenza Pandemic: Seasonal and H1N1 Influenza Vaccination Rates are Increasing in an IBD Population in 2009. Digestive Disease Week, New Orleans, May 2010.
18. Naik AS, Zadvornova Y, Issa M, Skaros S, Ward S, Ward A, Johnson K, Tyler K, Stein DJ, Perera LP, Ashwin N Ananthakrishnan. Tubular adenoma and low grade dysplasia in inflammatory bowel disease: Who is at risk? Digestive Disease Week, New Orleans, May 2010.
19. Selamawit Tarekegn, Kristin Oimoen, Yelena Zadvornova, Daniel Eastwood, Mazen Issa, Amar S. Naik, Daniel J. Stein, Nanda Venu, Lilani P. Perera Biologics Are Superior to Immunomodulators in Prevention of Post-Operative Recurrence of Crohn's Disease Digestive Disease Week 2011 Chicago, IL Mo1243 -- 2011
20. Adeeti Chiplunker, Yelena Zadvornova, Mazen Issa, Daniel J. Stein, Lilani P. Perera, Nanda Venu, Amar S. Naik Factors Associated with Repeat Hospitalizations in Inflammatory Bowel Disease Digestive Disease Week 2011 Chicago, IL. Tu1264 -- 2011
21. Amar S. Naik, Yelena Zadvornova, Sarah J. Lundeen, Daniel J. Stein, Nanda Venu, Mary F. Otterson, Mazen Issa, Lilani P. Perera Abdominal Venous Thrombosis Following Inflammatory Bowel Disease Related Surgeries While On Dalteparin Prophylaxis. Digestive Disease Week 2011 Chicago, IL Su1213 -- 2011
22. Mazen Issa, Yelena Zadvornova, Amar S. Naik, Daniel J. Stein, Nanda Venu, Lilani P. Perera High Rates of Escalation and Termination of Adalimumab Therapy and Patients Exposed to Infliximab . Digestive Disease Week 2011 Chicago, IL : Mo1226 -- 2011 AGA Poster of Distinction
23. Mazen Issa, Yelena Zadvornova, Daniel J. Stein, Nanda Venu, Lilani P. Perera, David G. Binion, Amar S. Naik Long-Term Use of Purine Analogues in Inflammatory Bowel Disease: A Single Referral Center Experience Digestive Disease Week 2011 Chicago, IL Tu1293 -- 2011
24. Roy Liu, Kristin Oimoen, Yelena Zadvornova, Jessica Pruszynski, Amar S. Naik, Daniel J. Stein, Nanda Venu, Lilani P. Perera Advanced Age At Diagnosis Does Not Negatively Impact Health Related Quality of Life in IBD: Performance of SIBDQ in a Longterm Cohort Study: Digestive Disease Week 2011 Chicago, IL Tu1312 -- 2011
25. Agnes Libot, Mazen Issa, Yelena Zadvornova, Daniel J. Stein, Nanda Venu, Lilani P. Perera, Amar S. Naik Initial Vancomycin Monotherapy Is Associated with Higher Rates of Subsequent Clostridium Difficile Infection in Inflammatory Bowel Disease Population Digestive Disease Week 2011 Chicago, IL Oral Presentation
26. Perera LP, Zadvornova Y, Binion DG, Guilday C, Stein DJ, Naik AS, Venu N, Best K, Skaros S. Long term outcomes of crohn’s disease patients on maintenance anti-TNF-α therapy. Presented as a poster at Digestive Disease Week 2012.
27. Perera LP, Zadvornova Y, Massey BT, Guilday C, Stein DJ, Naik AS, Best K, Skaros S. Increased rate of non-melanoma skin cancer detection with screening skin exam in inflammatory bowel disease: Is it time to recommend routine dermatology care? Presented as a poster at Digestive Disease Week 2012.
28. Perera LP, Zadvornova Y, Saeian K, Guilday C, Stein DJ, Naik AS, Venu N, Best K, Skaros S. Durability of Anti TNF α therapy in Ulcerative Colitis: Switching is an Effective Strategy in a Small Subset of patients. Presented as a poster at Digestive Disease Week 2012.
29. Perera LP, Zadvornova Y, Binion D, Guilday C, Stein DJ, Naik AS, Venu N, Best K, Skaros S. 10 year performance of anti TNF biologic therapy in inflammatory bowel disease. Digestive Disease Week 2012. San Diego, CA
30. Desai P, Sharma A, Naik AS, Otterson M, Zadvornova Y, Perera L, Venu N, Stein DJ. Timing of Pre-Operative Anti-Tumor Necrosis Factor Therapy Does Not Affect Early Post-Operative Complication Rates in Inflammatory Bowel Disease Patients Undergoing Intestinal Resection. DDW 2012
31. Stein DJ, Zadvornova Y, Lin E, Naik AS, Perera LP, Venu N, Otterson MF, Binion DG. Long-Term Clinical Outcomes Following Surgery in Crohn's Disease Patients on Combination Immunosuppression: Impact of Anastomotic Reconstruction on Quality of Life and Healthcare Utilization. Digestive Disease Week 2013 Orlando, FL
32. Venu M, Dodda A, Gonzaga JE, Naik AS, Venu N, Perera LP, Stein DJ. Outcomes in IBD Patients WHO Are Exposed to a Subsequent Anti-TNF Agent Following Anti-TNF Drug Induced Lupus-Like Reaction. Digestive Disease Week 2013 Orlando, FL
33. Radigan M, Guilday C, Visotcky A, Massey BT, Stein DJ, Naik AS, Venu N, Best K, Skaros S, Perera LP. Development of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease: Significant Association With Presence of Psychiatric Illness and Early Onset IBD. Digestive Disease Week 2013 Orlando, FL.
34. Guilday C, Eastwood D, Zadvornova Y, Stein DJ, Naik AS, Best K, Skaros S, Perera LP. Concomitant Use of Immunomodulator Therapy Results in Higher Serum Infliximab Levels Compared to Monotherapy Without Lowering Serum Haca Levels. Digestive Disease Week 2013 Orlando, FL.
35. Aadam AA, Saeian K, Massey BT, Stein DJ, Ashley L, Venu N, Venu M, Oh Y. Proximal Colon Retroflexion With Adult Versus Pediatric Colonoscopies. Digestive Disease Week 2013 Orlando, FL.
36. Ashir Z, Guilday C, Zadvornova Y, Stein DJ, Naik AS, Venu N, Best K, Skaros S, Saeian K, Perera LP. Mucosal Healing by Individual Anti TNF Agent in Crohn's Disease in Tertiary Care Setting. Digestive Disease Week 2013 Orlando, FL.
37. Naik AS, Zadvornova Y, Stein DJ, Shastri N, Venu M, Best K, Perera LP, Saeian K, Venu N. Factors Associated With 30 Day Re-Admission in Inflammatory Bowel Disease. Digestive Disease Week 2013 Orlando, FL.
38. Patel A, Zadvornova Y, Stein DJ, Naik AS, Best K, Idstein K, Massey BT, Perera LP. Anti TNF therapy in Inflammatory Bowel Disease: predictors of weight gain and development of obesity. Digestive Disease Week 2014. Chicago, IL.
39. Kanagala V, Zadvornova Y, Naik AS, Perera LP, Stein DJ. Asymptomatic Inflammatory Bowel Disease Patients with an Elevated CRP Are At Increased Risk of Hospitalization and Surgery Within Two Years of Follow up. Digestive Disease Week 2014. Chicago, IL.
40. Naik AS, Zadvornova Y, Stein DJ, Perera LP, Saeian K, Venu N. Impact of BMI on Inflammatory Bowel Disease Patients Diagnosed in Adolescence. Digestive Disease Week 2014. Chicago, IL.
41. Naik AS, Zadvornova Y, Stein DJ, Agrawal D, Venu N, Saeian K, Impact of Adenomatous Colon Polyps on Inflammatory Bowel Disease (IBD) CRC Surveillance., Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
42. Stein DJ, Ansari I, Cahill J, Agrawal D, Naik AS, Zadvornova Y. The Majority of Inflammatory Bowel Disease Patients Feel That an Elimination Diet Trial Had Resulted in Disease Symptom Improvement. Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
43. Modiri A, Naik AS, Rizvi S, Zadvornova Y, Stein DJ. Inflammatory Bowel Disease Patients With Solid Organ Transplants Who Require Anti-TNF Therapy Are Not at Increased Risk of Serious Infections. Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
44. Cahill J, Zadvornova Y, Naik AS, Agrawal D, Best K, Stein DJ, Azothioprine or 6-Mercaptopurnine Dose Does Not Affect Serum Infliximab Level or Rate of Antibody to Infliximab Formation, Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
45. Stein DJ, Rizvi S, Modiri A, Fang T, Naik AS. Two Case Reports of Toxic Megacolon From Clostridium difficile Infection Successfully Treated With Fecal Microbiota Therapy, Digestive Disease Week 2015, Washington DC, 5/16/2015 - 5/19/2015
46. A Yarur, V Kanagala, DJ Stein, F Czul, D Agrawal, Y Zadvornova, MA Quintero, MT Abreu. Higher Infliximab Trough Levels Are Associated With a Higher Rate of Perianal Fistula Healing in Patients With Crohn's Disease. Poster presentation at Digestive Disease Week. San Diego, CA. May 2016
47. Nichole Sly, PharmD, Shannon Werner, PharmD, Renee Pitt, PharmD, Ruta Bajorunaite, ScM, Lisa Rein, PhD, Daniel Stein, MD. Accelerated Dosing of Infliximab Is Not Associated With Improved Colectomy Rates in Hospitalized Severe Ulcerative Colitis Patients. World Congress of Gastroenterology at ACG2017 meeting in Orlando, FL. October 2017.
48. H Bader, AN Modiri, Y Zadvornova, DJ Stein. Mucosal Healing Rates in Patients with Upper Gastrointestinal Tract Crohn’s Disease. Poster Presentation. Digestive Disease Week, Chicago, IL, May 2017.
49. AJ Yarur, A Bruss, A Jain, V Kondragunta, TL Luna, K Hester, A Patel, D Agrawal, C Fox, S Werner, S Naik, DJ Stein. Higher Vedolizumab Levels are Associated with Deep Remission in Patients with Crohn's Disease and Ulcerative Colitis on Maintenance Therapy with Vedolizumab. Poster Presentation. Digestive Disease Week, Chicago, IL, May 2017.
50. AJ Yarur, A Bruss, B Berens, C Fox, PM Beniwal-Patel, A Patel, RC Ungaro, M Dubinsky, S Naik, DJ Stein. VEDOLIZUMAB LEVELS DURING INDUCTION ARE ASSOCIATED WITH LONG-TERM CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Poster Presentation. Digestive Disease Week 2018
51. Yarur AJ, Atkinson SN, Haque J, Beniwal-Patel PM, Stein DJ, Munoz-Price S. Differences In The Fecal Microbiome And Metabolome Of Patients With Acute Diarrhea Tested for Clostridioides Difficile Infection. Presented at DDW 2020 (Virtual Conference)
52. Nguyen BCH, Mulgund A, Beniwal-Patel PM, Patel A, Stein DJ, Yarur AJ. Endoscopic Assessment in Acute Severe Ulcerative Colitis is Safe and Associated with Short-term but not Long-term Outcomes. Poster Presentation. Digestive Disease Week 2020
53. Schwartz M, Stein DJ, Patel A, Beniwal-Patel PM, Otterson MF, Yarur AJ. Prevalence and Clinical Significance of Anastomotic Ring Inflammation After Ileal Resection and Ileo-Colonic Anastomosis in Patients With Crohn's Disease. Virtual Presentation at Digestive Disease Week 2020
54. Johnson L, Ghufran A, Beniwal-Patel P, Stein DJ. Future GI Fellowship Applicants to Gastroenterology fellowships more likely to be female despite perception of gender bias but underrepresented minority applicant disparities persist in setting of ongoing racial bias. ePoster Presentation for DDW Virtual 2021.
55. Yarur AJ, Bruss A, Nunez L, Moosreiner A, Stein DJ, Agrawal D, and others. Higher Visceral Adipose Tissue Is Associated With Lower Rates Of Steroid-Free Deep And Endoscopic Remission In Patients Starting Biologic Therapy For Inflammatory Bowel Diseases: Results From The Constellation Study. Gastroenterology. 2021 May;160 (6):S-79.
56. Mulgund, Aditi, Yarur, Andres, Stein, Daniel, Beniwal-Patel, Poonam: The implementation of a pilot study of a standardized inflammatory bowel disease curriculum for gastroenterology fellows. Crohn’s and Colitis Congress. January 2021. Virtual format.
57. Boscheutz N, Ghufran A, Stein D, Beniwal-Patel P. Male and Female fellows have similar motivators behind career planning. Presented as Poster Presentation, DDW 2021, virtual.
58. Hipp, L., Esteban, JP, Stein, D., Yarur, A., Beniwal-Patel, P. No Association Between Non-alcoholic Steatohepatitis or Advanced Fibrosis and IBD Clinical Remission at One and Five Years. Presented as Poster Presentation, DDW 2021, virtual.
59. Daniel Stein: Biologics and jak inhibitors decrease major cardiovascular events (mace) in IBD patients. Data from a large National cohort. Is it the mechanism of the drug or control of disease?. Presented as Poster Presentation, on May 20th, 2024, during the Research Forum component of the Annual DDW meeting in Washington, D.C.